United Therapeutics Corporation Restricted Cash and Investments, Noncurrent
United Therapeutics Corporation (UTHR) had Restricted Cash and Investments, Noncurrent of $5.39 million as of 2014-03-31, per its 10-Q filed 2014-04-29.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndInvestmentsNoncurrent · last filed 2014-04-29
- 2014-03-31: Restricted Cash and Investments, Noncurrent $5.39M.
- 2013-12-31: Restricted Cash and Investments, Noncurrent $5.37M.
- 2013-09-30: Restricted Cash and Investments, Noncurrent $5.36M.
- 2013-06-30: Restricted Cash and Investments, Noncurrent $5.41M.
| Period end | Restricted Cash and Investments, Noncurrent |
|---|---|
| 2014-03-31 | $5.39M 10-Q · filed 2014-04-29 |
| 2013-12-31 | $5.37M 10-Q · filed 2014-04-29 |
| 2013-09-30 | $5.36M 10-Q · filed 2013-10-29 |
| 2013-06-30 | $5.41M 10-Q · filed 2013-07-25 |
| 2013-03-31 | $5.38M 10-Q · filed 2013-04-25 |
| 2012-12-31 | $5.38M 10-K · filed 2014-02-25 |
| 2012-09-30 | $5.35M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $5.39M 10-Q · filed 2012-07-26 |
| 2012-03-31 | $5.37M 10-Q · filed 2012-04-26 |
| 2011-12-31 | $5.12M 10-K · filed 2013-02-26 |
| 2011-09-30 | $5.12M 10-Q · filed 2011-10-27 |
| 2011-06-30 | $5.12M 10-Q · filed 2011-07-28 |
| 2011-03-31 | $5.12M 10-Q · filed 2011-04-28 |
| 2010-12-31 | $5.12M 10-K · filed 2012-02-28 |
| 2010-09-30 | $40.27M 10-Q · filed 2010-10-28 |
| 2010-06-30 | $40.19M 10-Q · filed 2010-07-28 |
| 2009-12-31 | $39.98M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |